|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | |
| A61P 37/00 |
| (11) | Number of the document | 3229827 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15885769.8 |
| Date of filing the European patent application | 2015-12-12 | |
| (97) | Date of publication of the European application | 2017-10-18 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/079395 |
| Date | 2015-12-12 |
| (87) | Number | WO 2016/192819 |
| Date | 2016-12-08 |
| (30) | Number | Date | Country code |
| 201462091379 P | 2014-12-12 | US |
| (72) |
MULLER, Sylviane, FR
ZIMMER, Robert H., FR
BRIAND, Jean-Paul, FR
|
| (73) |
ImmuPharma France SA,
5, rue du Rhōne, 68100 Mulhouse,
FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, 3, Rue Michel-Ange, 75794 Paris, FR |
| (54) | MODIFIED PEPTIDES AND THEIR USE FOR TREATING CHRONIC INFLAMMATORY DISEASES |
| MODIFIED PEPTIDES AND THEIR USE FOR TREATING CHRONIC INFLAMMATORY DISEASES |